HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New phenotypic aspects in a family with Lynch syndrome II.

Abstract
Increasing attention has been given to hereditary nonpolyposis colorectal cancer (HNPCC). This report provides medical genetic/pathologic findings on an HNPCC kindred from southern Italy that shows criteria consistent with Lynch syndrome II. An international collaborative effort led to extension of this kindred with disclosure of a potentially new spectrum of phenotypic findings: an excess of gastric carcinoma; complete intestinal metaplasia and chronic atrophic gastritis restricted to the antrum; an apparent excess of colonic mucosal macrophagia, which by special stain appeared to be positive for mucin, with a constant content of both sialo and sulfomucin, a lack of iron, and an inconstant positivity for lysozyme obtained by immunoperoxidase technique; and findings of crypt atrophy of the colonic mucosa. During the relatively short period of investigation of this family, an intensive educational and surveillance program has been mounted in the interest of improving cancer control through direct application of knowledge of natural history and the risk factor evidence through pedigree assessment.
AuthorsG Cristofaro, H T Lynch, M L Caruso, A Attolini, G DiMatteo, P Giorgio, S Senatore, A Argentieri, E Sbano, G Guanti
JournalCancer (Cancer) Vol. 60 Issue 1 Pg. 51-8 (Jul 01 1987) ISSN: 0008-543X [Print] United States
PMID3581033 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Colorectal Neoplasms, Hereditary Nonpolyposis (epidemiology, pathology)
  • Endoscopy
  • Female
  • Gastritis, Atrophic (pathology)
  • Humans
  • Intestinal Mucosa (immunology, pathology)
  • Italy
  • Male
  • Middle Aged
  • Pedigree
  • Phenotype
  • Population Surveillance
  • Prospective Studies
  • Retrospective Studies
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: